Why the study?
Patients with ACS are at high risk for recurrent cardiovascular events and bleeding, particularly in Asian populations, but the long-term impact of multiple cardiovascular events and bleeding on outcomes remains unclear.
Does experiencing multiple cardiovascular events increase long-term mortality and bleeding risk in patients with acute coronary syndrome?
Does experiencing multiple cardiovascular events increase long-term mortality and bleeding risk in patients with acute coronary syndrome?
In patients with acute coronary syndrome, experiencing multiple cardiovascular events within 2 years is associated with significantly higher 5-year mortality and major bleeding compared to experiencing a single event.
Answers are grounded in this paper and cite their sources.
Recurrent events may worsen ACS prognosis in Asians; leaves open whether intensified prevention improves outcomes.
Background Patients with acute coronary syndrome (ACS) are at high risk for recurrent cardiovascular events and bleeding complications, particularly in Asian populations. The long‐term impact of multiple cardiovascular events and bleeding on outcomes remains unclear. Methods Using Taiwan's National Health Insurance Research Database, this retrospective cohort study included 28 086 patients with ACS categorized into single‐event and multiple‐event groups based on cardiovascular events occurring within 2 years of the index ACS event. After matching for age, sex, and event interval, 8756 patients were assigned to the multiple‐event group and 17 446 to the single‐event group. Results The multiple‐event group had higher comorbidity rates, including hypertension, prior coronary disease, heart failure, stroke, and chronic kidney disease. Over 5 years, the multiple‐event group had significantly higher all‐cause mortality (34.0% versus 24.0%) and cardiovascular mortality (11.2% versus 5.5%) compared with the single‐event group (both P <0.0001). Major (8.4% versus 1.6%) and minor (35.5% versus 7.4%) bleeding rates were also higher (both P <0.0001). Notably, major bleeding persisted beyond 3 months in the multiple‐event group, whereas the single‐event group showed reduced bleeding after 1 month. In the multiple‐event group, each additional major bleeding event was associated with earlier subsequent cardiovascular events (coefficient=−0.2875, P =0.0325). Conclusions Patients with ACS with multiple cardiovascular events have higher rates of all‐cause mortality, cardiovascular mortality, and major bleeding than patients with ACS with a single cardiovascular event. Major bleeding may also be associated with the risk of subsequent cardiovascular events, highlighting the importance of implementing a tailored antiplatelet strategy in Asian populations.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: